Innovation made easy

With MedMira’s patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our clients: A antibody (HIV, HCV, TP) and antigen (HBeAg and HBsAg) combination test. Two steps, 3 minutes procedure and 5 results. Only available from MedMira. Helping People Know…®
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities

Halifax, Nova Scotia, 21 December, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its VYRATMproduct line by launching its VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed to distinguish between SARS-CoV-2 and Influenza A or B infections. Furthermore, the Company takes […]